MMP-2 and TIMP-1 are derived from, not in response to, pancreatic cancer

Journal of Surgical Research

Volumn 102, Issue 1, 2002, Pages 35-38

  Bloomston, Mark ^a   Shafii, Alexis ^a   Zervos, Emmanuel E ^a   Rojiani, Amyn ^b   Rosemurgy, Alexander S ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER CELL; CANCER TRANSPLANTATION; CONFERENCE PAPER; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUDE MOUSE; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

EID: 0036350763     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2001.6317     Document Type: Conference Paper

References (23)

1. The matrix-degrading metalloproteinases
2. Collagenase in wound healing: Effect of wound age and type
3. Molecular cloning of murine 72-kD type IV collagenase and its expression during mouse development
4. Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer
5. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas
6. Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma
7. Expression of collagenase (MMP-2), stromelysin (MMP-3), and tissue inhibitor of metalloproteinases (TIMP-1) in pancreatic and ampullary disease
8. Inhibition of invasion and induction of apoptotic cell death of cell lines by overexpression of TIMP-3
9. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation
10. Tissue inhibitors of metalloproteinases: Evolution, structure, and function
11. Over expression of TIMP-1 by human pancreatic cancer cells reduces in-vitro invasion and in-vivo tumor growth
12. Callagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous carcinomas
13. Potential applications of tissue inhibitor of metalloproteinase (TIMP) overexpression for cancer gene therapy
14. Matrix metalloproteinase inhibition attenuates human pancreatic cancer growth in vitro and decreases mortality and tumorigenesis in vivo
15. The use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase technique: A comparison between ABC and unlabeled antibody (PAP) procedures
16. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck
17. Addition of matrix metalloproteinase inhibition to conventional cytotoxic therapy reduces tumor implantation and prolongs survival in a murine model of human pancreatic cancer
18. Matrix metalloproteinase inhibition suppresses MMP-2 activity and activation of PANC-1 cells in vitro
19. Marimastat in patients with advanced pancreatic cancer
20. Matrix metalloproteinase inhibition improves survival in an orthotopic model of human pancreatic cancer
21. Effect of matrix metalloproteinase inhibition on pancreatic cancer invasion and metastasis: An additive strategy for cancer control
22. Matrix metalloproteinase inhibitors: Applications in oncology
23. Antitumor effect of a new selective matrix metallo-proteinase inhibitor, MMI-166, on experimental pancreatic cancer